Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder
- PMID: 28628699
- PMCID: PMC6007012
- DOI: 10.1001/jamapediatrics.2017.1269
Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder
Conflict of interest statement
Comment on
-
Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.JAMA Pediatr. 2017 Aug 1;171(8):747-755. doi: 10.1001/jamapediatrics.2017.0745. JAMA Pediatr. 2017. PMID: 28628701 Free PMC article.
References
-
- Kaiser Family Foundation. [Accessed March 30, 2017];State Health Facts: opioid overdose deaths by age group. 2016 http://kff.org/other/state-indicator/opioid-overdose-deaths-by-age-group....
-
- Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies–tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–2066. - PubMed
-
- Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
